一个特定的炎症抑制纤维细胞亚群,其特征是MHCII表达在人类扩张性心肌病的特征
Xi Fan1, Kai Huang1, Yuming Wu2
1Department of Cardiothoracic Surgery, Huashan Hospital of Fudan University, 12 Wulumuqi Rd, Shanghai, 200040, China.
Molecular and cellular biochemistry
|March 11, 2024
概括
研究人员发现了一个新的纤维细胞亚型,抗原呈现纤维细胞 (apFBs),在扩张性心肌病 (DCM). 这些apFBs表达MHCII基因并有助于抑制炎症,为心力衰竭提供潜在的治疗点.
科学领域:
- 心血管生物学 心血管生物学
- 免疫学 免疫学 免疫学
- 单细胞基因组学 单细胞基因组学
背景情况:
- 扩张性心肌病 (DCM) 是心力衰竭的主要原因,通常需要移植.
- 纤维细胞是DCM纤维炎性微环境中的关键参与者.
- 在DCM中纤维细胞的细胞多样性和免疫相互作用仍然不太清楚.
研究的目的:
- 确定新的纤维细胞亚群及其在DCM微环境中的作用.
- 研究DCM中纤维细胞和免疫细胞之间的细胞间通信.
- 探索已识别的纤维细胞特征的诊断和预后潜力.
主要方法:
- 从人类心脏组织 (健康和DCM) 的单细胞RNA测序 (ScRNA-Seq) 数据的综合分析.
- 免疫光染色以确认已识别的纤维细胞亚型的存在.
- 分析细胞间通信通路和基因表达特征.
- 使用大量RNA测序数据集进行验证.
主要成果:
- 鉴定了一种新型纤维细胞亚型,即抗原呈现纤维细胞 (apFBs),其特征是MHCII基因表达.
- apFBs表现出IFN-γ响应基因和JAK-STAT通路活性的高表达.
- 在DCM中的apFB-CD4+T细胞通信中对抗炎症的连接体-受体对 (TGFB-TGFR,CLEC2B-KLRB1,CD46-JAG1) 的升调.
- apFB签名与免疫抑制相关,并显示出诊断/预后价值.
结论:
- 在DCM中发现了一种表达MHCII的新型纤维细胞亚群 (apFBs).
- 这些apFB在DCM微环境中抑制炎症.
- 研究结果提供了对DCM纤维炎性情景的见解,并建议apFB作为治疗点.
相关概念视频
Introduction to Fibroblasts
4.8K
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
4.8K
Myocarditis I: Introduction
605
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
605
Cardiomyopathy II: Dilated Cardiomyopathy
786
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
786
Cardiomyopathy III: Hypertrophic Cardiomyopathy
754
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
754
Cardiomyopathy IV: Restrictive Cardiomyopathy
877
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
877


